This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe
Europe's premier partnering event
Save the date for next yearNovember 3–5, 2025 | Vienna, Austria

Wojciech Nowak
Group Senior Director, Global Governmental and Public Affairs at Novartis International
Speaker

Profile

  • Chairman of the Healthcare Council, Executive Committee and Board of Directors Member, EuropaBio.
  • Group Senior Director, Global Governmental and Public Affairs, Novartis International, Switzerland (Responsibility for ca. 30 countries incl. Western & Eastern Europe, Central Asia).
  • Board Member, Joint Chamber of Commerce Switzerland-Eastern Europe, Central Asia, South Caucasus (JCC).

Multicultural, inclusive and reflective leader who lived in 6 countries on 3 continents. Robust understanding of the global healthcare policies and life-sciences business with more than 25 years of experience in policy creation related to healthcare systems, EU integration and global pharmaceutical market.

Started his career at the Ministry of Health (Poland) counselling policy leaders on European integration and healthcare matters, followed by assignments in the Ministry of Health and Solidarity of the Republic of France (Paris, France) and Health Directorate of the European Commission (DG SANCO, Luxembourg).

After joining private sector has been serving in a number of senior leadership roles of growing responsibility in healthcare companies(GlaxoSmithKline, Abbott, Novartis) on country, regional and global levels (Poland, Belgium, Switzerland).

Educated in Poland, United States, Netherlands, Switzerland, with the background in political sciences, international relations (Warsaw’s University, Poland; European Institute of Public Administration, Maastricht, Netherlands) and business administration (EMBA from the IMD Business School Lausanne, Switzerland) he is an expert in healthcare systems, global healthcare policies and international business. Passionate about delivering access and best healthcare outcomes to patients around the World.

Agenda Sessions

  • “Merry‐Go‐Round”: Impact of the evolving pharmaceutical legislation on investor and company strategies in the life science ecosystem

    15:00